Lexicon Pharmaceuticals
LXRX
#7493
Rank
NZ$0.69 B
Marketcap
NZ$1.93
Share price
-19.44%
Change (1 day)
41.15%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -NZ$0.13 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are NZ$70.86 Million. In 2024 the company made an earning of -NZ$0.34 Billion a decrease over its 2023 earnings that were of -NZ$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.13 Billion-63.58%
2024 -NZ$0.34 Billion13.15%
2023 -NZ$0.3 Billion73.74%
2022 -NZ$0.17 Billion16.16%
2021 -NZ$0.15 Billion49.82%
2020 -NZ$97.26 Million-147.19%
2019 NZ$0.20 B-203.42%
2018 -NZ$0.2 Billion-15.31%
2017 -NZ$0.24 Billion0.2%
2016 -NZ$0.24 Billion2920.7%
2015 -NZ$7.78 Million-95.33%
2014 -NZ$0.17 Billion-3.61%
2013 -NZ$0.18 Billion-5.52%
2012 -NZ$0.19 Billion-4.17%
2011 -NZ$0.2 Billion15.5%
2010 -NZ$0.17 Billion8.36%
2009 -NZ$0.16 Billion-4.81%
2008 -NZ$0.17 Billion28.79%
2007 -NZ$0.13 Billion35.71%
2006 -NZ$91.71 Million52.91%
2005 -NZ$59.98 Million-23.89%
2004 -NZ$78.8 Million-24.19%
2003 -NZ$0.11 Billion-0.48%
2002 -NZ$0.11 Billion44.12%
2001 -NZ$72.46 Million23.01%
2000 -NZ$58.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$11.78 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.65 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.54 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$45.57 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$38.59 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.12 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$15.76 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA